XML 54 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
(LOSS) PER SHARE (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Calculation of (Loss) Per Share
Calculation of (loss) per share:
Three Months Ended
March 31,
(in thousands, except per share amounts)20242023
Net (loss)$(12,124)$(20,774)
Weighted-average common shares outstanding84,266 82,604 
(Loss) per share, basic$(0.14)$(0.25)
Net (loss)$(12,124)$(20,774)
Weighted-average common shares outstanding, assuming dilution (1) (2) (3)
84,266 82,604 
(Loss) per share, diluted$(0.14)$(0.25)
Outstanding anti-dilutive stock options and RSUs (4)
3,171 1,348 
(1) All dilutive securities are excluded in periods of loss as their inclusion would be anti-dilutive.
(2) The shares underlying the conversion options in the Company’s Notes are included using the if-converted method, if dilutive in the period. If the outstanding conversion options were fully exercised, the Company would issue approximately 3.7 million shares as of March 31, 2024.
(3) The Company’s Capped Call Transactions represent the equivalent of approximately 3.7 million shares of the Company’s common stock (representing the number of shares for which the Notes are convertible) as of March 31, 2024. The Capped Call Transactions are expected to reduce common stock dilution and/or offset any potential cash payments the Company must make, other than for principal and interest, upon conversion of the Notes, with such reduction and/or offset subject to a cap of $196.44. The Capped Call Transactions are excluded from weighted-average common shares outstanding, assuming dilution, in all periods as their effect would be anti-dilutive.
(4) Outstanding stock options and RSUs that were anti-dilutive under the treasury stock method in the period were excluded from the computation of diluted (loss) per share. These awards may be dilutive in the future.